DE69104615D1 - Diphenylpiperazinderivat. - Google Patents

Diphenylpiperazinderivat.

Info

Publication number
DE69104615D1
DE69104615D1 DE69104615T DE69104615T DE69104615D1 DE 69104615 D1 DE69104615 D1 DE 69104615D1 DE 69104615 T DE69104615 T DE 69104615T DE 69104615 T DE69104615 T DE 69104615T DE 69104615 D1 DE69104615 D1 DE 69104615D1
Authority
DE
Germany
Prior art keywords
action
cardiac muscles
diphenylpiperazine
derivative
diphenylpiperazine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69104615T
Other languages
English (en)
Other versions
DE69104615T2 (de
Inventor
Noboru Kaneko
Makoto Takeishi
Tatsushi Oosawa
Kouji Akimoto
Hideo Oota
Tatsuo Nakajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69104615D1 publication Critical patent/DE69104615D1/de
Publication of DE69104615T2 publication Critical patent/DE69104615T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69104615T 1990-07-10 1991-07-10 Diphenylpiperazinderivat. Expired - Lifetime DE69104615T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2182095A JP2651043B2 (ja) 1990-07-10 1990-07-10 ジフェニルメチルピペラジン誘導体
PCT/JP1991/000924 WO1992000962A1 (fr) 1990-07-10 1991-07-10 Derive de diphenylmethylpiperazine

Publications (2)

Publication Number Publication Date
DE69104615D1 true DE69104615D1 (de) 1994-11-17
DE69104615T2 DE69104615T2 (de) 1995-03-23

Family

ID=16112265

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69104615T Expired - Lifetime DE69104615T2 (de) 1990-07-10 1991-07-10 Diphenylpiperazinderivat.

Country Status (12)

Country Link
US (1) US5304558A (de)
EP (1) EP0541802B1 (de)
JP (1) JP2651043B2 (de)
CN (1) CN1037840C (de)
AT (1) ATE112764T1 (de)
AU (1) AU8212591A (de)
CA (1) CA2087032C (de)
DE (1) DE69104615T2 (de)
RU (1) RU2091379C1 (de)
TW (1) TW198717B (de)
WO (1) WO1992000962A1 (de)
ZA (1) ZA915366B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658963A (en) * 1995-02-02 1997-08-19 Bisco, Inc. One-component primer/bonding-resin systems
WO2001022968A1 (fr) * 1999-09-30 2001-04-05 Noboru Kaneko Agents anticancereux
EA006079B1 (ru) * 2000-03-31 2005-08-25 Пфайзер Продактс Инк. Новые пиперазиновые производные
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
DK1423381T3 (da) * 2001-09-06 2007-05-07 Schering Corp 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
JP2007525165A (ja) 2003-03-07 2007-09-06 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク タイプ1ライアノジン受容体に基づく方法
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
JP5318938B2 (ja) 2011-06-09 2013-10-16 株式会社アエタスファルマ ジフェニルメチルピペラジン誘導体、及びそれを用いた医薬組成物
JP6021616B2 (ja) * 2012-12-04 2016-11-09 株式会社アエタスファルマ 3−ピペラジニル−1−ピペリジニル−プロパン誘導体及びそれを含有してなる医薬組成物
KR102257892B1 (ko) 2014-11-26 2021-05-28 삼성전자주식회사 개선된 nfc 안테나 및 그 안테나를 갖는 전자 장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR65270B (en) * 1978-10-10 1980-07-31 Fujisawa Pharmaceutical Co Isatin derivatives and processes for the preparation thereof
DE3536797A1 (de) * 1985-10-16 1987-04-16 Studiengesellschaft Kohle Mbh Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung
HU198052B (en) * 1986-02-14 1989-07-28 Sandoz Ag Process for producing purine derivatives substituted by side chain containing piperazinyl ring and pharmaceutical compositions comprising such compounds
ZA871078B (en) * 1986-02-14 1988-09-28 Sandoz Ltd Purine derivatives,their preparation and medicaments containing them
US4885300A (en) * 1988-03-03 1989-12-05 Ortho Pharmaceutical Corporation 4-Substituted pyrazolo[3,4-D]pyrimidine derivatives
US5215987A (en) * 1990-04-23 1993-06-01 Ortho Pharmaceutical Corporation Substituted benzhydryl 2-hydroxypropyl piperazine derivatives

Also Published As

Publication number Publication date
DE69104615T2 (de) 1995-03-23
EP0541802A4 (en) 1993-05-26
US5304558A (en) 1994-04-19
ZA915366B (en) 1992-04-29
CA2087032A1 (en) 1992-01-11
TW198717B (de) 1993-01-21
ATE112764T1 (de) 1994-10-15
WO1992000962A1 (fr) 1992-01-23
JPH0469377A (ja) 1992-03-04
EP0541802A1 (de) 1993-05-19
JP2651043B2 (ja) 1997-09-10
RU2091379C1 (ru) 1997-09-27
EP0541802B1 (de) 1994-10-12
AU8212591A (en) 1992-02-04
CN1037840C (zh) 1998-03-25
CA2087032C (en) 1999-06-15
CN1058963A (zh) 1992-02-26

Similar Documents

Publication Publication Date Title
ATE112764T1 (de) Diphenylpiperazinderivat.
DK0486948T3 (da) Forbindelser, der hæmmer retrovirale proteaser
ZW15789A1 (en) Substituted thiazoles and their use as fungicides
DE69407409T2 (de) Azolylamin-derivat
ATE269290T1 (de) Benzoylderivate
NZ237565A (en) Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof
NO307047B1 (no) Nye hydroksyetylaminosulfonamider som er nyttige som retrovirale proteasehemmere, farmasøytisk preparat inneholdende slike, og anvendelse derav
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
GR3020953T3 (en) Agents for preserving wood or composite-wood materials against insects
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
DE69202166T2 (de) Verwendung von Tetrahydrothienopyridinderivate als Angiogenese-Inhibitoren.
DE50101861D1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
ES2096874T3 (es) Inhibidor de la proteasa de hiv util para el tratamiento del sida.
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
IL82382A (en) N-(pyrid-3-yl)cyclopropane carboxamides and their use as fungicides
ATE88634T1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
ATE114309T1 (de) N-azabicyclo(3.3.0>octanamide von aromatischen säuren.
DE69213049D1 (de) Isoquinolinderivate
ATE158503T1 (de) Aids-virus-infektion hemmende zusammensetzung
ES2115178T3 (es) Derivados de indanotrionas y de hidrazidas y su aplicacion terapeutica.
ATE154243T1 (de) Hemmstoff der blutgefässhypertrophie
KR960702310A (ko) 도파민 재소비 저해제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition